Maintaining results of successful induction treatment is an important goal in myeloma and the use of maintenance treatment to achieve this has been investigated for a number of years. Here, members of the International Myeloma Working Group review the relevant data and draw a consensus on maintenance treatment in myeloma.
This paper, produced by an expert panel on behalf of the European Myeloma Network, reviews the available evidence and provides recommendations regarding the optimal use of lenalidomide and low-dose dexamethasone in relapsed or refractory myeloma patients.
This paper is a summary report, produced by members of the European Myeloma Network, following a series of discussions by an expert panel to identify specific indications and consensus technical approaches for interphase FISH.
In this article, an inter-disciplinary expert panel of specialists in myeloma and myeloma-related bone disease review the current evidence for bipshosphonate use in myeloma and provide recommendations to support the treatment of myeloma bone disease.